IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson Innovation - Jjdc, Inc.

Q1 2021 Holdings

Filed 2021-05-06 | 17 holdings | $221.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals(ARWR)COM04280A100$216.2M3,260,86997.6%
Aldeyra Therapeutics, Inc.(ALDX)COM01438T106$4.7M394,8342.1%
Fate Therapeutics, Inc.(FATE)COM31189P102$278.6K3,379,0640.1%
Protagonist Therapeutics Inc.(PTGX)COM74366E102$63.4K2,449,1830.0%
Legend Biotech Corporation(LEGN)SPONSORED ADS52490G102$47.3K1,629,1730.0%
Vor Biopharma, lnc.COM929033108$46.3K1,074,6580.0%
MeiraGTx Holdings plc(MGTX)COMG59665102$41.8K2,898,5500.0%
Fusion Pharmaceuticals Inc.COM36118A100$39.3K3,670,5160.0%
BiomX Inc.COM09090D103$15.2K2,133,4020.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$9.5K728,9440.0%
PhaseBio Pharmaceuticals, Inc.COM717224109$5.6K1,607,0440.0%
Senseonics Holdings, Inc.(SENS1GBP)COM81727U105$1.3K492,2690.0%
Castlight Health Inc.(CSLT1EUR)CL B14862Q100$1.2K811,2950.0%
Tracon Pharmaceuticals, Inc.COM89237H209$69184,0030.0%
Catalyst Biosciences, Inc.COM14888D208$33766,9510.0%
Graybug Vision, Inc.COM SHS38942Q103$27549,5470.0%
Pulmonx Corporation(LUNG)COM745848101$2585,6390.0%